US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof
Patent 11926657 was granted and assigned to MedImmune, LLC on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
